1. Updates in Management of Atopic Dermatitis From Real Patient Cases

2. This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data that were presented in abstract form.

3. Changing Treatment Landscape for Atopic Dermatitis

4. Adult Case: John

5. Adult Case: John (cont)

6. Pediatric Case: Aidan

7. Pediatric Case: Aidan (cont)

8. Confirming Diagnosis of AD

9. Differential Diagnoses to Consider

10. Reasons for Treatment Failure

11. Reasons for Treatment Failure (cont)

12. Reasons for Treatment Failure (cont)

13. Systematic Management of a Patient With AD

14. Managing a Patient With Uncontrolled AD

15. Candidates for Systemic Therapy

16. Steps Prior to Starting a Patient on Systemic Treatment

17. Consider Impact of AD on Quality of Life

18. On- and Off-Label Systemic Therapies for AD

19. Engaging the Patient in a Shared Decision-Making Process

20. Key Takeaways

21. Concluding Remarks